Skip to main content
. 2018 Oct 24;62(11):e00892-18. doi: 10.1128/AAC.00892-18

TABLE 1.

Characteristics of patients with PVCRBSI

Parameter Value for the parameter (n = 711)a
Median age (range [yr]) 67 (55–77)
Male sex 467 (65.7)
Phlebitis 636 (89.5)
Catheter culture
    Negative 12 (1.7)
    Positive 154 (21.7)
    Not performed 545 (76.7)
Prior hospital admission 99 (13.9)
Days since hospital admission
    Median no. of days (range) 7 (4–12)
    0–7 390 (54.9)
    8–14 161 (22.6)
    15–21 60 (8.4)
    >21 68 (9.6)
    Unknown 32 (4.5)
Days since catheter placement
    Median no. of days (range) 5 (3–7)
    0–3 201 (28.3)
    4–6 245 (34.5)
    7–9 122 (17.2)
    10–12 46 (6.5)
    13–15 15 (2.1)
    16–18 6 (0.8)
    >19 7 (1.0)
    Unknown 69 (9.7)
Fever 690 (97.0)
Shock 19 (2.7)
Prior surgery 77 (10.8)
Prior nonsurgical invasive procedure 81 (11.4)
Urinary catheter 133 (18.7)
Cirrhosis 102 (14.3)
Diabetes 163 (22.9)
Pulmonary disease 57 (8.0)
HIV infection 23 (3.2)
Chronic kidney disease 67 (9.4)
Cardiac disease 249 (35.0)
Hematological malignancy 53 (7.5)
Solid organ malignancy 112 (15.8)
Neutropenia 14 (2.0)
Solid organ transplant 32 (4.5)
Corticosteroid therapy 129 (18.1)
McCabe, ultimately or rapidly fatal outcome 278 (39.1)
7-Day mortality 26 (3.7)
30-Day mortality 53 (7.5)
Persistent bacteremia 33 (4.6)
Correct empirical treatment 386 (54.3)
Prior antibiotic treatment 169 (23.8)
Microbial etiology
    Gram-positive cocci 533 (75.0)
        Staphylococcus aureus 327 (46.0)
        Coagulase-negative staphylococci 178 (25.0)
        Enterococcus spp. 26 (3.7)
    Gram-negative bacilli 162 (22.8)
        Klebsiella spp. 40 (5.6)
        Pseudomonas aeruginosa 32 (4.5)
        Escherichia coli 29 (4.1)
        Enterobacter spp. 28 (3.9)
        Serratia spp. 5 (0.7)
        Acinetobacter spp. 5 (0.7)
    Candida spp. 9 (1.3)
a

Values are given as number of patients (percentage) unless otherwise indicated.